• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 25 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 25 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV435T
Device Problem Reset Problem (3019)
Patient Problem Hydrocephalus (3272)
Event Date 03/08/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient data - height: 170 cm.Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that a progav valve had an adjustment issue.A patient underwent a retro-auricular shunt system implantation on (b)(6) 2019.Sometime later, an adjustment defect was noted.On (b)(6) 2019, the shunt was replaced due to this malfunction.Further details were not available.
 
Manufacturer Narrative
Visual inspection: a deformation of, as well as bloody deposits on, the outer housing of the progav valve was observed through the visual inspection.The progav valve housing was subsequently measured and confirmed the presence of a deformation.The housing deformation measured at -0.0715mm, outside the tolerance of 0+- 0.02mm.Permeability test: a permeability test has shown that the progav valve is permeable.Adjustment test: the progav valve was tested and is freely adjustable.However, the test also showed that the brake function is not present, allowing the valve to self-adjust.Braking force and brake function test: the brake functionality test has shown that the brake function did not operate as expected.The results indicate that the rotor no longer performs as required.Results: it should be noted the shunt system was received dry (not submerged in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquid and blood can have on product performance.In spite of this, we have investigated the system to the best of our abilities.First, we performed a visual inspection of the progav valve.A deformation of the outer housing of the progav valve was observed through the visual inspection the deformation was confirmed through a measurement of the paralitity of the valve housing.Next, we tested the permeability of the valve, as well as the brake functionality and brake force.The progav valve was permeable.However, the brake function was not present allowing the valve to self-adjust and indicating that the rotor has been compromised.Finally, we have dismantled the valve.Inside the valve, we have found build-up of substances (likely protein).Based on our investigation, we confirm that the brake function of the valve no longer operates as expected; this is likely due to the observed deformation of the valve housing.Additionally, the deposits observed inside the valve could have contributed to the compromise of the system.As described in our literature, the problem encountered is one of the known, inevitably risks of hc-therapy by shunt implants.The cause of the deformation of the progav valve and the resultant defect of the rotor could not be determined though out investigation.Significant outside pressure, for example by too much force from the pogav adjustment tool or by a fall or impact to the head of the patent, can compromise the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS W/SA 25 A.CONTROL RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8487823
MDR Text Key141073427
Report Number3004721439-2019-00083
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/08/2023
Device Model NumberFV435T
Device Catalogue NumberFV435T
Device Lot Number20039502
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/15/2019
Distributor Facility Aware Date03/21/2019
Initial Date Manufacturer Received 03/18/2019
Initial Date FDA Received04/05/2019
Supplement Dates Manufacturer Received04/03/2019
Supplement Dates FDA Received11/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient Weight100
-
-